SULJE VALIKKO

avaa valikko

Progress in Drug Research
49,60 €
Birkhauser Verlag AG
Sivumäärä: 286 sivua
Asu: Pehmeäkantinen kirja
Painos: Softcover reprint of
Julkaisuvuosi: 2012, 16.10.2012 (lisätietoa)
Kieli: Englanti
Hypertension is one of the cardiovascular diseases which is most common throughout the world. It is generally defined as an elevation of systolic and/or diastolic arterial blood pressure, which is 120/80 mm Hg in normal situation. A value of 140/90 mm is generally accepted as the upper limit of normotension. Hypertension with certain risk factors such as hypercholes­ terolemia, diabetes, smoking and a family history of vascular disease pre­ disposes to arteriosclerosis and consequent cardiovascular morbidity and mortality. The treatment of hypertension leads to reduced risk of hyperten­ sive renal failure, haemorrhagic stroke, myocardial infarction and cardiac failure. In most cases, the cause of the hypertension can not be clearly defined. Such hypertension is termed as essential hypertension. In a few cases (5- 15%), the hypertension is secondary to definable causes, such as renal artery stenosis, a pheochromocytoma, or an endocrine disorder. This type of hyper­ tension is known as secondary hypertenSion. Although the exact etiology of essential hypertension is still not well known, the following factors are sup­ posed to play causative roles.

Contributions by: J. Szmuskovicz, S.P. Gupta, B. Kundu, S.K. Khare, S.K. Rastogi, P. Spence, M.S. Barnette

Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tilaustuote | Arvioimme, että tuote lähetetään meiltä noin 17-20 arkipäivässä
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Progress in Drug Researchzoom
Näytä kaikki tuotetiedot
ISBN:
9783034897495
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste